The project, titled Fish Feed on Blue Prescription and funded by the Norwegian Seafood Research Fund, was carried out in collaboration with BioMar and the Norwegian University of Life Sciences.
The U.S. company's integrated aquaponics system enables it to raise Atlantic salmon in a fully controlled environment, free from antibiotics and pesticides.